Capricorn Partners Launches €51M Fund to Support Dutch Healthtech Innovations
Netherlands, Friday, 10 January 2025.
Capricorn Partners has raised €51 million to invest in healthtech startups, aiming to bridge funding gaps and enhance healthcare through digital and medtech innovations in Europe.
Strategic Investment in Healthcare Innovation
Capricorn Partners announced the first close of its Capricorn Healthtech Fund II on January 8, 2025, securing €51 million from prominent investors including Invest-NL, Quest for Growth, and AG Insurance/Ageas Group [1][4]. The fund represents a significant commitment to transforming healthcare through technological innovation, focusing on both digital health solutions and medical technologies [2]. Investment Associate at Invest-NL, Mats Wassink, highlights the fund’s crucial role in addressing a critical funding gap for companies that have outgrown seed financing but aren’t yet ready for larger European funds [1].
Investment Strategy and Focus
The fund will target investments ranging from €1 million to €5 million per company, specifically focusing on late-seed to Series B-stage startups [1]. With plans to support 10-15 companies across Europe, the fund maintains a particular emphasis on the Benelux region [2]. Filip Pintelon, Investment Partner for Health at Capricorn, emphasizes their mission to integrate breakthrough innovations into mainstream healthcare practices, ultimately improving accessibility and efficiency [1][2].
Addressing Healthcare Challenges
This investment initiative comes at a crucial time when healthcare systems face mounting pressures from aging populations and increasing chronic disease prevalence [2]. According to the European Commission’s 2024 report, healthcare expenditure accounts for approximately 10% of GDP in most EU countries [2]. The fund’s focus on digital health and medical technologies aims to advance value-based healthcare by enabling personalization across the entire patient journey, from prevention to treatment [2].
Track Record and Future Prospects
Capricorn Partners, founded in 1993, brings over a decade of experience in scaling healthcare companies [1][2]. Their portfolio includes successful exits such as Cartagenia, Bluebee, and Sequana Medical, as well as current success stories like icometrix [2]. While the current close stands at €51 million, Capricorn Partners aims to reach a total fund size of €100 million and is actively seeking additional investors [1].